missing translation for 'onlineSavingsMsg'
Få mere at vide

STEMCELL Technologies FK-866

Artikelnummer. 17189981
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
17189981 10 mg
17179981 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 17189981 Leverandør STEMCELL Technologies Leverandørnr. 1000264

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

Nicotinamide phosphoribosyltransferase inhibitor

  • FK-866 is a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme that regulates NAD+ biosynthesis from the natural precursor nicotinamide (Cameron et al.; Hasmann & Schemainda)
  • In hepatocarcinoma cells, FK-866 activates AMP-activated protein kinase (AMPK) and downregulates mammalian target of rapamycin (mTOR) signaling (Schuster et al.)
  • FK-866 can be used to deplete NAD+, a central metabolism cofactor (Cameron et al.; Hasmann & Schemainda; Jadeja et al.)
  • Depletes NAD+ and induces delayed cell death by apoptosis in HepG2 human liver carcinoma cells (IC50 = ∼1 nM; Hasmann & Schemainda)
  • Triggers dose-dependent cytotoxicity in multiple myeloma cells (Cea et al.)
  • Induces autophagic death in neuroblastoma SH-SY5Y cells (IC50 = 0.93 nM; Billington et al.)

Tekniske data

CAS 658084-64-1
Mængde 10 mg
Molekylær formel C24H29N3O2
Renhed ≥98%
Produkttitel
Vælg et problem

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.